On November 2, Aimed Alliance hosted a legislative briefing on facilitating access to medications for opioid use disorders (“MOUD”). The objective of this legislative briefing was to educate patient and professional advocacy groups on the state of drug poisoning in the United States, and the need for the United States Senate to pass S.3257. The bill would expand the “14-day limit” to 60-days to ensure patients with opioid use disorder (OUD) can access their treatments. To learn more about the urgent need to expand access to MOUD, read the Executive Summary here.
Read the letter to Sen. Jeanne Shaheen signed by 20 organizations here.
Last Updated on December 12, 2022 by Aimed Alliance
